$7.46B
Revenue
$369.39M
Net Income
18.15%
Gross Margin
7.22%
Op. Margin
$297.25M
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $1.81B | $2.01B | $1.89B | $1.75B | $1.83B | $2.14B | $2.02B |
| Revenue Growth % (YoY) | -1.0% | -6.1% | -6.1% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $1.50B | $1.45B | $1.59B | $1.56B | $1.68B | $1.91B | $1.77B |
| Gross Profit | $309.95M | $559.24M | $299.96M | $185.68M | $153.95M | $238.73M | $247.27M |
| Gross Margin % | 17.1% | 27.8% | 15.8% | 10.6% | 8.4% | 11.1% | 12.3% |
| Operating Expenses | $1.71B | $1.65B | $1.80B | $1.76B | $1.88B | $2.11B | $1.97B |
| Operating Income | $99.26M | $358.52M | $96.76M | $-15.78M | $-46.96M | $36.43M | $48.64M |
| Operating Margin % | 5.5% | 17.8% | 5.1% | -0.9% | -2.6% | 1.7% | 2.4% |
| Interest Expense | $24.81M | $55.66M | $37.90M | $19.44M | $19.99M | $47.84M | $27.20M |
| Other Income/Expense | $-22.00K | $-109.00K | $-163.00K | $-371.00K | $-422.00K | $1.25M | $-124.00K |
| Income Before Tax | $93.48M | $345.34M | $76.35M | $-37.29M | $-71.89M | $13.95M | $25.30M |
| Income Tax Expense | $18.08M | $82.71M | $16.89M | $-6.89M | $-16.19M | $6.46M | $6.67M |
| Net Income | $77.70M | $262.63M | $59.46M | $-30.40M | $-55.70M | $7.49M | $18.64M |
| Net Margin % | 4.3% | 13.0% | 3.1% | -1.7% | -3.0% | 0.3% | 0.9% |
| Basic EPS | 1.59 | 5.29 | 1.18 | -0.57 | -0.98 | 0.13 | 0.33 |
| Diluted EPS | 1.54 | 5.16 | 1.17 | -0.57 | -0.98 | 0.13 | 0.32 |
| Basic Shares Outstanding | - | 49.6M | 50.4M | 53.8M | -508K | 55.7M | 57.2M |
| Diluted Shares Outstanding | - | 50.9M | 50.8M | 53.8M | -1.3M | 56.2M | 58.0M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $164.11M | $159.06M | $169.19M | $133.75M | $191.92M | $182.98M | $179.66M |
| Accounts Receivable | $312.67M | $349.12M | $386.55M | $384.30M | $398.13M | $429.74M | $486.30M |
| Inventory | $1.23B | $1.35B | $1.04B | $1.06B | $1.09B | $1.07B | $1.26B |
| Other Current Assets | $10.37M | $122.23M | $122.52M | $46.04M | $21.34M | $82.20M | $51.72M |
| Total Current Assets | $1.78B | $1.98B | $1.72B | $1.62B | $1.77B | $1.77B | $1.98B |
| Goodwill | $127.28M | $129.28M | $129.28M | $129.28M | $129.28M | $129.28M | $129.28M |
| Intangible Assets | $9.48M | $8.79M | $9.03M | $9.28M | $9.52M | $9.76M | $10.01M |
| Other Non-current Assets | $197.03M | $236.18M | $315.82M | $269.41M | $235.09M | $272.22M | $252.82M |
| Total Assets | $3.83B | $4.08B | $3.90B | $3.75B | $3.83B | $3.85B | $3.94B |
| Accounts Payable | $341.56M | $447.62M | $438.71M | $410.67M | $436.80M | $464.77M | $549.04M |
| Accrued Liabilities | $467.04M | $475.44M | $435.19M | $293.96M | $344.19M | $285.00M | $284.89M |
| Deferred Revenue | $6.70M | - | - | - | $16.20M | - | - |
| Total Current Liabilities | $1.11B | $1.31B | $1.21B | $1.04B | $1.10B | $1.05B | $1.21B |
| Long-term Debt | $802.87M | $962.06M | $1.11B | $1.15B | $1.11B | $1.04B | $1.05B |
| Other Non-current Liabilities | $52.65M | $60.17M | $60.84M | $60.42M | $59.94M | $131.15M | $103.68M |
| Total Liabilities | $2.28B | $2.68B | $2.75B | $2.64B | $2.64B | $2.60B | $2.67B |
| Common Stock | $497.00K | $502.00K | $507.00K | $523.00K | $552.00K | $559.00K | $568.00K |
| Retained Earnings | $541.38M | $491.75M | $245.55M | $214.26M | $295.85M | $366.67M | $381.28M |
| Total Stockholders Equity | $1.51B | $1.40B | $1.15B | $1.11B | $1.19B | $1.25B | $1.27B |
| Total Liabilities & Equity | $3.83B | $4.08B | $3.90B | $3.75B | $3.83B | $3.85B | $3.94B |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $77.70M | $262.63M | $29.06M | $-30.40M | $-55.70M | $7.49M | $14.89M |
| Depreciation & Amortization | $36.74M | $36.28M | $34.71M | $36.59M | $34.91M | $31.88M | $64.80M |
| Stock-based Compensation | $4.84M | $11.76M | $8.02M | $3.55M | $3.22M | $22.48M | $19.50M |
| Deferred Income Tax | $19.15M | $81.27M | $8.58M | $-6.89M | $-11.80M | $9.24M | $3.53M |
| Change in Receivables | $-35.78M | $-48.90M | $-11.45M | $-13.80M | $-31.20M | $57.24M | $114.01M |
| Change in Inventory | $-120.94M | $265.05M | $-46.58M | $-31.87M | $9.80M | $-72.65M | $101.27M |
| Operating Cash Flow | $93.80M | $351.54M | $132.18M | $-1.40M | $-15.47M | $99.24M | $20.75M |
| Capital Expenditure | $27.54M | $121.34M | $89.06M | $40.93M | $47.68M | $87.86M | $59.53M |
| Investing Cash Flow | $-23.73M | $-119.06M | $-86.79M | $-40.92M | $-47.67M | $-86.32M | $-57.99M |
| Debt Repayment | $1.17B | $5.18B | $3.32B | $1.39B | $1.24B | $2.83B | $1.46B |
| Stock Repurchased | $27.57M | $97.28M | $80.83M | $51.10M | $15.29M | $126.68M | $103.51M |
| Financing Cash Flow | $-65.01M | $-265.34M | $-68.11M | $-15.85M | $72.09M | $-109.05M | $-62.21M |
| Net Change in Cash | $5.06M | $-32.86M | $-22.72M | $-58.17M | $8.95M | $-96.12M | $-99.44M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $2.01B | - | $5.65B | - |
| Cost of Revenue | $1.45B | - | $4.61B | - |
| Operating Expenses | $1.65B | - | $5.21B | - |
| Operating Income | $358.52M | - | $439.50M | - |
| Interest Expense | $21.27M | - | $55.66M | - |
| Other Income/Expense | $-109.00K | - | $-643.00K | - |
| Income Before Tax | $345.34M | - | $384.39M | - |
| Income Tax Expense | $82.71M | - | $92.70M | - |
| Net Income | $262.63M | $18.64M | $291.69M | - |
| Basic EPS | 5.29 | - | 5.69 | - |
| Diluted EPS | 5.16 | - | 5.62 | - |
| Basic Shares Outstanding | $49.63M | - | $51.24M | - |
| Diluted Shares Outstanding | $50.90M | - | $51.88M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $159.06M | $191.92M |
| Accounts Receivable | $349.12M | $398.13M |
| Inventory | $1.35B | $1.09B |
| Other Current Assets | $122.23M | $92.53M |
| Total Current Assets | $1.98B | $1.77B |
| Goodwill | $129.28M | $129.28M |
| Intangible Assets | $8.79M | $9.52M |
| Other Non-current Assets | $236.18M | $235.09M |
| Total Assets | $4.08B | $3.83B |
| Accounts Payable | $447.62M | $436.80M |
| Accrued Liabilities | $475.44M | $344.19M |
| Total Current Liabilities | $1.31B | $1.10B |
| Long-term Debt | $962.06M | $1.11B |
| Other Non-current Liabilities | $60.17M | $59.94M |
| Total Liabilities | $2.68B | $2.64B |
| Common Stock | $502.00K | $552.00K |
| Retained Earnings | $491.75M | $295.85M |
| Total Stockholders Equity | $1.40B | $1.19B |
| Total Liabilities & Equity | $4.08B | $3.83B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $262.63M | $18.64M | $291.69M | - |
| Depreciation & Amortization | $36.28M | - | $107.58M | - |
| Stock-based Compensation | - | - | $11.76M | - |
| Deferred Income Tax | - | - | $81.27M | - |
| Change in Receivables | - | - | $-48.90M | - |
| Change in Inventory | - | - | $265.05M | - |
| Operating Cash Flow | - | - | $351.54M | - |
| Capital Expenditure | - | - | $121.34M | - |
| Investing Cash Flow | - | - | $-119.06M | - |
| Debt Repayment | - | - | $5.18B | - |
| Stock Repurchased | - | - | $97.28M | - |
| Financing Cash Flow | - | - | $-265.34M | - |
| Net Change in Cash | - | - | $-32.86M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.